Trial Profile
A Randomized, Double-Blind Multicenter Pilot Study vs. Placebo for the Evaluation of Efficacy and Tolerability of Tauroursodeoxycholic Acid Administered by Oral Route as Add on Treatment in Patients Affected by Amyotrophic Lateral Sclerosis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2023
Price :
$35
*
At a glance
- Drugs Ursodoxicoltaurine (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- Acronyms TUDCA-ALS
- 05 Dec 2023 Trial design presented in the Trials
- 23 Mar 2012 Planned end date changed from 1 Dec 2010 to 1 Apr 2012 as reported by ClinicalTrials.gov.
- 23 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.